Literature DB >> 15899539

Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002.

Adam Roth1, Morten Sodemann, Henrik Jensen, Anja Poulsen, Per Gustafson, Justino Gomes, Queba Djana, Marianne Jakobsen, May-Lill Garly, Amabelia Rodrigues, Peter Aaby.   

Abstract

The rates of positive tuberculin skin test (TST) reactions and BCG scarring after BCG vaccination vary between studies and populations. Tuberculin reactivity and BCG scarring may be related to better child survival in low-income countries. We therefore studied determinants for TST reaction and scarring in Guinea-Bissau. In a cohort of children born in suburban Bissau from March 2000 to July 2002, we assessed a Mantoux test with Purified protein derivative (PPD) (SSI, 2 T.U.) at 2 (2689 children), 6 (N=2148) and 12 months (N=1638) of age, and BCG scar was assessed at 2 (N=2698) and 6 months (N=2225) of age. In a subgroup of the children the vaccination technique was monitored by direct observation of post-vaccination wheal and route of administration. Three different types of BCG vaccine supplied by the local Extended Programme on Immunization were used. At 6 months of age the rate of PPD reactors (>1mm) after BCG vaccination was 25% and the rate of scarring was 89%. One BCG strain was associated with fewer PPD reactors (OR=0.54 (0.31-0.91)) and BCG scars (OR=0.13 (0.05-0.37)) and larger post-vaccination wheals produced more PPD reactions (OR 1.21 (95% CI 1.02-1.43)) and BCG scars (OR 1.66 (1.24-2.21)). In the multivariable analyses of BCG-vaccinated children assessed at 6 months of age, monitoring of vaccination technique and type of BCG vaccine were important. This was not changed by control for other determinants, including sex, season, vaccination place, birthplace, ethnic group, low birth weight, place of residence, education and civil status of mother. We reason that vaccination technique and BCG strain are important for PPD reaction and scarring in response to BCG vaccination. Considering that these responses are associated with better infant survival, the importance of monitoring vaccination technique and of different BCG strains should be evaluated with respect to infant mortality.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15899539     DOI: 10.1016/j.vaccine.2004.10.022

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Effects of antenatal and postnatal environments on CD4 T-cell responses to Mycobacterium bovis BCG in healthy infants in the Gambia.

Authors:  David J C Miles; Marianne van der Sande; Sarah Crozier; Olubukola Ojuola; Melba S Palmero; Mariama Sanneh; Ebrima S Touray; Sarah Rowland-Jones; Hilton Whittle; Martin Ota; Arnaud Marchant
Journal:  Clin Vaccine Immunol       Date:  2008-04-09

Review 2.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

3.  Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries.

Authors:  Peter Aaby; Christine Benn; Jens Nielsen; Ida Maria Lisse; Amabelia Rodrigues; Henrik Ravn
Journal:  BMJ Open       Date:  2012-05-22       Impact factor: 2.692

4.  A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe.

Authors:  Hennie D Geldenhuys; Helen Mearns; Jennifer Foster; Eugene Saxon; Benjamin Kagina; Laura Saganic; Courtney Jarrahian; Michele D Tameris; One B Dintwe; Michele Van Rooyen; Kany-Kany A Luabeya; Gregory Hussey; Thomas J Scriba; Mark Hatherill; Darin Zehrung
Journal:  Vaccine       Date:  2015-04-07       Impact factor: 3.641

5.  Both very low- and very high in vitro cytokine responses were associated with infant death in low-birth-weight children from Guinea Bissau.

Authors:  Andreas Andersen; Kristoffer J Jensen; Christian Erikstrup; Henrik Ravn; Ane B Fisker; Ida M Lisse; Erliyani Sartono; Peter Aaby; Maria Yazdanbakhsh; Christine S Benn
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

6.  Factors associated with birthweight and adverse pregnancy outcomes among children in rural Guinea-Bissau - a prospective observational study.

Authors:  Alexander Dahl Stjernholm; Sanne Marie Thysen; Igualdino Da Silva Borges; Ane Bærent Fisker
Journal:  BMC Public Health       Date:  2021-06-17       Impact factor: 3.295

7.  Two-step tuberculin skin testing in school-going adolescents with initial 0-4 millimeter responses in a high tuberculosis prevalence setting in South India.

Authors:  Maitreyi Murthy; Sumithra Selvam; Nelson Jesuraj; Sean Bennett; Mark Doherty; Harleen M S Grewal; Mario Vaz
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

8.  Disappointment and adherence among parents of newborns allocated to the control group: a qualitative study of a randomized clinical trial.

Authors:  Sandra Meinich Petersen; Vibeke Zoffmann; Jesper Kjærgaard; Lone Graff Stensballe; Lone Graff Steensballe; Gorm Greisen
Journal:  Trials       Date:  2014-04-15       Impact factor: 2.279

9.  Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial.

Authors:  Kristoffer Jarlov Jensen; Nanna Larsen; Sofie Biering-Sørensen; Andreas Andersen; Helle Brander Eriksen; Ivan Monteiro; David Hougaard; Peter Aaby; Mihai G Netea; Katie L Flanagan; Christine Stabell Benn
Journal:  J Infect Dis       Date:  2014-09-09       Impact factor: 5.226

Review 10.  100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19.

Authors:  Niyati Lobo; Nathan A Brooks; Alexandre R Zlotta; Jeffrey D Cirillo; Stephen Boorjian; Peter C Black; Joshua J Meeks; Trinity J Bivalacqua; Paolo Gontero; Gary D Steinberg; David McConkey; Marko Babjuk; J Alfred Witjes; Ashish M Kamat
Journal:  Nat Rev Urol       Date:  2021-06-15       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.